NewsMarkets

Science

Enzyme PLA2G2D Regulates Anti-Tumour Immunity

Research shows that inhibiting the enzyme PLA2G2D in tumour-draining lymph nodes improves anti-tumour immunity in mouse models.

1 publisher · 1 article · first seen 9 Sept 2026 · updated 49d ago

Headline and summary written by an AI model from the linked article; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

1 publisher has covered this in 1 article since 9 Sept 2026. Nature published first, on 9 September at 00:00 UTC.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity Nature ·
Embed this story

Paste this into any web page to show the live odds, with a link back here.